Breakdown | TTM | Jun 2024 | Jun 2023 | Jun 2022 |
---|---|---|---|---|
Income Statement | ||||
Total Revenue | 61.10M | 64.00M | 40.20M | 24.46M |
Gross Profit | 53.00M | 47.00M | 24.30M | 16.31M |
EBITDA | 26.60M | 49.40M | 33.80M | 52.93M |
Net Income | -3.50M | 6.90M | 20.20M | 49.61M |
Balance Sheet | ||||
Total Assets | 1.46B | 1.44B | 1.72B | 693.60M |
Cash, Cash Equivalents and Short-Term Investments | 4.70M | 19.90M | 7.60M | 2.69M |
Total Debt | 491.70M | 481.10M | 703.70M | 22.29M |
Total Liabilities | 519.80M | 521.50M | 766.20M | 39.51M |
Stockholders Equity | 931.00M | 912.60M | 951.20M | 654.09M |
Cash Flow | ||||
Free Cash Flow | 15.40M | 6.40M | 888.90M | -473.92M |
Operating Cash Flow | 15.40M | 6.40M | 11.10M | 19.96M |
Investing Cash Flow | 138.70M | 41.50M | -961.90M | -522.47M |
Financing Cash Flow | -117.70M | -35.60M | 944.10M | 501.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | AU$589.69M | 10.94 | 25.52% | 4.50% | 6.85% | 237.34% | |
63 Neutral | AU$411.89M | 20.57 | 4.00% | 7.02% | -0.80% | ― | |
61 Neutral | AU$434.64M | 78.69 | -0.39% | 10.63% | -14.19% | -115.93% | |
55 Neutral | AU$97.05M | ― | -1.43% | 3.13% | -6.61% | -47.55% | |
55 Neutral | AU$758.62M | ― | -8.21% | 7.98% | -9.52% | 47.94% | |
53 Neutral | $1.19B | 3.49 | -2.19% | 6.01% | -2.24% | -167.40% | |
53 Neutral | AU$75.62M | ― | -26.33% | 11.53% | -7.19% | -94.37% |
HealthCo Healthcare & Wellness REIT, part of HMC Capital, has announced the schedule for releasing its full-year financial results for the year ended June 30, 2025. The results will be disclosed over several days in August 2025, with associated conference calls and webcasts available for stakeholders. This announcement is crucial for investors and stakeholders as it provides insights into the company’s financial performance and strategic positioning in the healthcare and wellness real estate sector.
The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare & Wellness REIT announced a preliminary unaudited portfolio valuation of $1.5 billion, reflecting a 4.3% gross decrease from the previous valuation due to cap rate expansion. The company will not declare a quarterly distribution for the period from April to June 2025 to preserve balance sheet liquidity. Alternative hospital operators are conducting due diligence on all 11 private hospitals owned by HCW and the Unlisted Healthcare Fund. This decision and the valuation adjustment indicate a strategic focus on maintaining financial stability amid market fluctuations.
The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare & Wellness REIT and the Unlisted Healthcare Fund have agreed to a short-term partial rent deferral with Healthscope and its Receivers to ensure the continuity of services at 11 private hospitals. This agreement includes immediate payment of outstanding rents for March and April 2025, and 85% of rent for May 2025, with the remaining 15% deferred until September 2025. The landlords are also in discussions about the Healthscope sale process and have received interest from other hospital operators to re-tenant the facilities, indicating a strategic move to maintain operations and explore new partnerships.
The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HealthCo Healthcare & Wellness REIT (ASX:HCW) and the Unlisted Healthcare Fund (UHF) have announced that two entities within the Healthscope group have entered into receivership and administration. However, the entities that HCW and UHF contract with remain operational and unaffected by the receivership. The existing legal rights of HCW and UHF, including cross default and termination rights, remain intact, although termination rights are not currently enforceable. This situation underscores the resilience of HCW’s operations and its strategic positioning in the healthcare property market, ensuring stakeholders that their investments remain secure despite the challenges faced by Healthscope.
The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.
HMC Capital presented at the 2025 Macquarie Australia Conference, highlighting its strategic focus and operational strengths. The presentation underscores HMC Capital’s ability to manage substantial funds and execute complex deals, reinforcing its position in the alternative asset management industry and its commitment to delivering strong returns for its investors.